Obviously, patients with higher CTSC level exhibited significantly shorter survival, validated by 2 independent cohorts of patients with breast and colon cancer who had received chemotherapy (Figure 5H and Supplemental Figure 9D). This evidence concerns the gene CTSC and malignant colon neoplasm.